Results 291 to 300 of about 315,545 (404)
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian +6 more
wiley +1 more source
Treatment with L-type amino acid transporter 1 inhibitor JPH203 enhances protein synthesis in C2C12 myotubes. [PDF]
Takegaki J, Saneyasu T, Honda K.
europepmc +1 more source
Cell Toxicity and Autophagy in A549 Cells Treated With Surface‐Functionalized Graphene Derivatives
ABSTRACT Graphene oxide and its derivatives have unique physical and chemical properties with applications in many different fields. However, their biological effects and mechanisms of intracellular toxicity have not been completely clarified. In this study, we investigated the cytotoxic and autophagic activities of graphene oxide and its derivatives ...
Tae Yun Park +6 more
wiley +1 more source
Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis. [PDF]
Du H +8 more
europepmc +1 more source
Endoplasmic Reticulum and Golgi Localization Sequences for Mammalian Target of Rapamycin
Xiangyu Liu, Xiao-Feng Zheng
openalex +1 more source
Impact of organic pollutants on phenotype and gene expression in human breast cancer cells
ABSTRACT Human exposure to industrial chemical compounds is widespread and, although often beneficial, prolonged contact may contribute to disease development, including cancer. While many studies have shown organic pollutants (OP) are cytotoxic, few have explored how long‐term exposure alters cell phenotype.
Camila Confortin +7 more
wiley +1 more source
Reprogramming chemically induced dimerization systems with genetically encoded nanobodies. [PDF]
Wang T +6 more
europepmc +1 more source
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan +3 more
wiley +1 more source

